Back to Jeremy Grantham
Jeremy Grantham → TMO via Grantham, Mayo, Van Otterloo & Co. LLC
Jeremy Grantham TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
9
Latest value
$1.4B
Q2 2026
Peak value
$1.4B
First seen
Q2 2024
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.4B | 2.74M | — | — |
| Q1 2026 | $1.2B | 2.50M | — | — |
| Q4 2025 | $1.4B | 2.41M | — | — |
| Q3 2025 | $1B | 2.14M | — | — |
| Q2 2025 | $750.6M | 1.85M | — | — |
| Q1 2025 | $724.5M | 1.46M | — | — |
| Q4 2024 | $569.1M | 1.09M | — | — |
| Q3 2024 | $281.1M | 454.4K | — | — |
| Q2 2024 | $235.4M | 425.6K | — | — |